<code id='C16612BAFB'></code><style id='C16612BAFB'></style>
    • <acronym id='C16612BAFB'></acronym>
      <center id='C16612BAFB'><center id='C16612BAFB'><tfoot id='C16612BAFB'></tfoot></center><abbr id='C16612BAFB'><dir id='C16612BAFB'><tfoot id='C16612BAFB'></tfoot><noframes id='C16612BAFB'>

    • <optgroup id='C16612BAFB'><strike id='C16612BAFB'><sup id='C16612BAFB'></sup></strike><code id='C16612BAFB'></code></optgroup>
        1. <b id='C16612BAFB'><label id='C16612BAFB'><select id='C16612BAFB'><dt id='C16612BAFB'><span id='C16612BAFB'></span></dt></select></label></b><u id='C16612BAFB'></u>
          <i id='C16612BAFB'><strike id='C16612BAFB'><tt id='C16612BAFB'><pre id='C16612BAFB'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:888
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Readout Newsletter: Geron, Novo Nordisk, WuXi updates
          Readout Newsletter: Geron, Novo Nordisk, WuXi updates

          KayanaSzymczakforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Kenai launches with $82 million for Parkinson’s stem cell therapy

          AdobeThedreamofbeingabletopluckacelltherapyoffofafreezershelfandspeedilygiveittocancerpatientsismate